How big is the transfection technologies market today, and what are its future growth expectations?
The transfection technologies market size has grown strongly in recent years. It will grow from $1.21 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, expanded applications of transfection technologies, growing demand for cell & gene therapy, increasing R&D investments, and rising cancer incidences.
The transfection technologies market size is expected to see strong growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to the rising rate of chronic and immunological diseases, the growing need for cell-based therapies, increasing demand for protein production, rising investments and funding in the development of drug delivery systems, and rising demand for monoclonal antibodies. Major trends in the forecast period include a rise in research and development in the field of cell-based therapies, adoption of the technologically advanced transfection method, increasing demand for advanced therapeutic delivery systems, increasing use of dual-reporter assays and co-transfection experiments, and increasing focus on personalized medicine.
Get Your Free Sample of The Global Transfection Technologies Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp
What have been the primary factors driving the transfection technologies market’s growth?
The rise in gene therapy is expected to propel the growth of the transfection technologies market going forward. Gene therapy is a technique that aims to treat or prevent diseases by modifying genes, which includes inserting, repairing, or replacing faulty genes. Gene therapy’s rise is driven by progress in genetic research, enhanced delivery methods, and its ability to treat previously incurable genetic conditions. Transfection technologies are crucial for gene therapy, facilitating the precise, safe, and effective delivery of genetic material into cells. They support both temporary and permanent genome modifications, essential for treating genetic diseases and cancers. For instance, in July 2023, according to the report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, and Citeline, a US-based provider of drugs and devices, by the end of the first quarter (Q1) of 2023, there were 247 gene therapies in Phase II. This number increased by 5%, reaching 260 by the end of the second quarter (Q2). Therefore, the rise in gene therapy is driving the growth of the transfection technologies market.
What are the key segments within the transfection technologies market?
The transfection technologiesmarket covered in this report is segmented –
1) By Product: Kits And Reagents, Equipment, Other Products
2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods
3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users
Subsegments:
1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents
2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment
3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report
Which key players are shaping the transfection technologies market?
Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.
How will emerging trends drive the transfection technologies market throughout the forecast period?
Major companies in the transfection technologies market are focused on developing advanced technology, such as mechanoporation transfection systems, to enable more complex and personalized applications in research and therapeutics. Mechanoporation transfection systems use mechanical forces to create temporary pores in cell membranes, allowing genetic material to enter cells. This method is efficient and minimally invasive, preserving better cell viability. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched CellPore, an innovative transfection system. This system includes a benchtop unit and the CellPore Transfection Kit 300, which comes with a specialized reagent kit and single-use delivery cartridges. Using controlled, rapid deformation in microfluidic channels, CellPore efficiently introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, ensuring minimal cell disruption and high viability. These features are critical for advancing research and the development of cutting-edge cell and gene therapies.
How do regional factors impact the transfection technologies market, and which region is the largest contributor?
North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Transfection Technologies Market Report 2025 Offer?
The transfection technologies market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Transfection technologies are the intentional introduction of nucleic acids into cells using chemical, physical, or biological methods to modify gene expression or genetic content. It is used to study gene function, produce proteins, silence genes via ribonucleic acid(RNA) interference (siRNA/miRNA), and potentially treat genetic diseases by introducing functional genes.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19228
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
